Affordable Access

deepdyve-link
Publisher Website

Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods.

Authors
  • Sood, Vikas1
  • Bhansali, Anil1
  • Mittal, Bhagwant Rai1
  • Singh, Baljinder1
  • Marwaha, Neelam1
  • Jain, Ashish1
  • Khandelwal, Niranjan1
  • 1 Vikas Sood, 2 Nuclear Medicine Centre, RCC, Indira Gandhi Medical College, Shimla 171001, India. , (India)
Type
Published Article
Journal
World Journal of Diabetes
Publisher
Baishideng Publishing Group Co (World Journal of Diabetes)
Publication Date
Jul 15, 2017
Volume
8
Issue
7
Pages
381–389
Identifiers
DOI: 10.4239/wjd.v8.i7.381
PMID: 28751962
Source
Medline
Keywords
License
Unknown

Abstract

Targeted route showed a significant reduction in Insulin requirement at the end of six months of study period whereas the intravenous group failed to show reduction.

Report this publication

Statistics

Seen <100 times